MOUNT LAUREL, N.J., July 16 /PRNewswire-FirstCall/ -- MedQuist Inc. (Pink Sheets: MEDQ) announced that The NASDAQ Stock Market, LLC, has approved the Company's application for listing on its Global Market. The Company's stock will begin trading on the Global Market under the ticker symbol "MEDQ" effective tomorrow, July 17, 2008. The company has been trading on the Pink Sheets since 2004.
Mark Ivie, MedQuist's Interim President and CEO, stated, "We are pleased to announce the Company's listing on the NASDAQ Global Market. We believe that NASDAQ will provide our investors with a more transparent electronic market to aid their trading efficiency and liquidity needs."
About MedQuist:
MedQuist is the largest Medical Transcription Service Organization (MTSO) in the world, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions -- including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors -- help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit http://www.medquist.com/.
Disclosure Regarding Forward-Looking Statements:
Some of the statements in this press release constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These statements are not historical facts but rather are based on the company's current expectations, estimates and projections regarding the company's business, operations and other factors relating thereto. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates" and similar expressions are used to identify these forward-looking statements. The forward-looking statements contained in this press release include, without limitation, statements about the company's expected listing on the NASDAQ Global Market. These statements are only predictions and as such are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict, including, without limitation, the risk that the settlement agreement is not consummated, the risk that the case is not dismissed with prejudice, and the risk of possible future claims against the company. For a discussion of these risks, uncertainties and assumptions, any of which could cause our actual results to differ from those contained in the forward-looking statement, see the section of the company's Annual Report on Form 10-K for the year ended December 31, 2007, entitled "Risk Factors" and discussions of potential risks and uncertainties in the MedQuist's subsequent filings with the Securities and Exchange Commission.
